Eleni Chantzoura

Associate Director, Immune Receptor Discovery
AgenTus Therapeutics
Eleni Chantzoura
AgenTus Therapeutics, a biopharmaceutical company, is focused on the discovery, development, and commercialization of breakthrough "living drugs" to advance cures for cancer patients. AgenTus will employ naturally-derived and engineered receptors, specifically T Cell Receptors (TCRs) and Chimeric Antigen Receptors (CARs), designed to supercharge human immune effector cells to seek and destroy cancer. AgenTus will also aim to advance adoptive cell therapy formats which would enable off-the-shelf living drugs.

Sessions

No data was found

Cell Series 2019
Post-Event Report

Statistics, feedback, photos and more from last year's event